Loading clinical trials...
Loading clinical trials...
RATIONALE: Drugs such as valproic acid may make thyroid cancers more radioiodine sensitive, which will allow for detection of tumor and make further ablation treatment effective.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of California, San Francisco
Collaborators
NCT04541381 · Gastrointestinal Cancer, Head and Neck Cancer, and more
NCT07209189 · Head and Neck Cancer, Squamous Cell Carcinoma, and more
NCT06477692 · Head and Neck Cancer
NCT05874492 · Fibrosis, Breast Cancer, and more
NCT07467083 · Head and Neck Cancer
UCSF Comprehensive Cancer Center
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions